Since the discovery of the mutation of the Htt gene at exon 1 leading to polyglutamine repeats in mHtt as the cause of HD in 1993, the scientific world has struggled to identify the mechanisms through which the mutated protein leads to HD pathology and the clinical manifestations, and find efficient ways to counteract them in order to treat HD. The gene discussed is HTT; the disease is Huntington disease.